Page last updated: 2024-08-22

platinum and arginyl-glycyl-aspartic acid

platinum has been researched along with arginyl-glycyl-aspartic acid in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (14.29)18.2507
2000's1 (14.29)29.6817
2010's4 (57.14)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
De Giglio, E; Sabbatini, L; Zambonin, PG1
Barnés, CM; Barnes, KR; Haskel, A; Lippard, SJ; Mukhopadhyay, S; Short, SM1
Chen, Y; Liu, B; Tang, BZ; Yuan, Y1
Gai, S; Gu, R; Gulzar, A; He, F; Lv, R; Yang, G; Yang, P; Zhang, S; Zhong, C1
Cheng, Y; Wang, Y; Yan, Y; Zhang, Q; Zhou, Z1
Chatzisideri, T; Dalezis, P; Gederaas, OA; Katsamakas, S; Lazarides, T; Lindgren, M; Nikolakaki, E; Sarli, V; Sigala, I; Thysiadis, S; Trafalis, D1
Chen, Y; Han, R; Hao, Y; He, X; Liu, Q; Liu, T; Qian, Z; Yang, C; Yang, Y1

Other Studies

7 other study(ies) available for platinum and arginyl-glycyl-aspartic acid

ArticleYear
Development and analytical characterization of cysteine-grafted polypyrrole films electrosynthesized on Pt- and Ti-substrates as precursors of bioactive interfaces.
    Journal of biomaterials science. Polymer edition, 1999, Volume: 10, Issue:8

    Topics: Amino Acid Sequence; Animals; Cell Adhesion; Cells, Cultured; Coated Materials, Biocompatible; Cysteine; Electrochemistry; Oligopeptides; Peptides; Platinum; Polymers; Protein Binding; Pyrroles; Rats; Spectrometry, X-Ray Emission; Surface Properties; Titanium

1999
Conjugated platinum(IV)-peptide complexes for targeting angiogenic tumor vasculature.
    Bioconjugate chemistry, 2008, Volume: 19, Issue:1

    Topics: Amino Acid Motifs; Animals; Cattle; CD13 Antigens; Cell Line, Tumor; Cell Proliferation; Cisplatin; Dose-Response Relationship, Drug; Endothelial Cells; Humans; Inhibitory Concentration 50; Integrin alphaV; Neoplasms; Neovascularization, Pathologic; Oligopeptides; Organometallic Compounds; Peptides; Platinum

2008
A targeted theranostic platinum(IV) prodrug containing a luminogen with aggregation-induced emission (AIE) characteristics for in situ monitoring of drug activation.
    Chemical communications (Cambridge, England), 2014, Apr-14, Volume: 50, Issue:29

    Topics: Cell Line, Tumor; Cell Survival; Coordination Complexes; Fluorescent Dyes; Humans; MCF-7 Cells; Microscopy, Confocal; Oligopeptides; Platinum; Prodrugs; Pyridines

2014
Synthesis, luminescence, and anti-tumor properties of MgSiO3:Eu-DOX-DPP-RGD hollow microspheres.
    Dalton transactions (Cambridge, England : 2003), 2015, Nov-14, Volume: 44, Issue:42

    Topics: Animals; Antineoplastic Agents; Cell Survival; Doxorubicin; Drug Carriers; Endocytosis; Erythrocytes; Europium; HeLa Cells; Hemolysis; Humans; Light; Mice; Microspheres; Neoplasms; Oligopeptides; Platinum; Porosity; Prodrugs; Silicon Dioxide; Transplantation, Heterologous

2015
Dendrimer-Templated Ultrasmall and Multifunctional Photothermal Agents for Efficient Tumor Ablation.
    ACS nano, 2016, 04-26, Volume: 10, Issue:4

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Copper; Dendrimers; Fluorescent Dyes; Humans; Light; Male; Metal Nanoparticles; Mice; Mice, Inbred BALB C; Oligopeptides; Optical Imaging; Palladium; Particle Size; Peptide Fragments; Photosensitizing Agents; Phototherapy; Platinum; Surface Properties

2016
Synthesis and biological evaluation of a Platinum(II)-c(RGDyK) conjugate for integrin-targeted photodynamic therapy.
    European journal of medicinal chemistry, 2017, Dec-01, Volume: 141

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Integrins; Molecular Structure; Oligopeptides; Organoplatinum Compounds; Photochemotherapy; Platinum; Rats; Structure-Activity Relationship

2017
RGD peptide modified platinum nanozyme Co-loaded glutathione-responsive prodrug nanoparticles for enhanced chemo-photodynamic bladder cancer therapy.
    Biomaterials, 2023, Volume: 293

    Topics: Cell Line, Tumor; Glutathione; Humans; Nanoparticles; Oligopeptides; Paclitaxel; Photochemotherapy; Photosensitizing Agents; Platinum; Polyethylene Glycols; Prodrugs; Tumor Microenvironment; Urinary Bladder Neoplasms

2023